IP Library Granted Patent US 9,522,874
Granted Patent B2
US 9,522,874 · App. 14/539,126 · Granted Dec 20, 2016

Lysine-glutamic acid dipeptide derivatives

Inventor: Kurt Puentener (Basel, CH)
Assignee: Hoffmann-La Roche Inc.
C07C271/22C07C269/06C07C2103/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,522,874
App. No.
14/539,126
Granted
Dec 20, 2016
Kind
B2
Abstract

The invention relates to compounds of the formula I. The compounds of formula I are versatile peptide intermediates for the solid phase peptide synthesis (SPPS) of peptide drugs which comprise a Glu-fatty alkyl side chain building block attached to a Lys-part of the peptide chain.

Claims (52)

1. A compound of the formula

wherein,

R 1 is t-butyl,

R 2 is hydrogen or an ester protecting group,

R 3 is hydrogen or an amino protecting group, and

R 4 is C 12-20 -alkyl,

and enantiomers, diastereomers and salts thereof.

2. The compound of claim 1 wherein, the ester protecting group is selected from C 1-4 -alkyl, optionally substituted with phenyl, C 2-4 -alkenyl, piperidinyl or dimethylaminoboranyl.

3. The compound of claim 1 , wherein

R 2 is hydrogen or C 2-4 -alkenyl.

4. The compound of claim 1 , wherein R 2 is hydrogen or allyl.

5. The compound of claim 1 , wherein R 3 is 9H-fluoren-9-ylmethoxycarbonyl.

6. The compound of claim 1 , wherein R 4 is C 14-16 -alkyl.

7. A compound of the formula

wherein,

R 1 is t-butyl,

R 2 is hydrogen or an ester protecting group,

R 3 is hydrogen or an amino protecting group, and

R 4 is C 12-20 -alkyl,

and salts thereof.

8. The compound of claim 7 , wherein,

R 2 is hydrogen, R 3 is 9H-fluoren-9-ylmethoxycarbonyl and R 4 is C 15 -alkyl; or

R 2 is allyl, R 3 is 9H-fluoren-9-ylmethoxycarbonyl and R 4 is C 15 -alkyl.

9. The compound of claim 7 , wherein,

R 2 is hydrogen, R 3 is 9H-fluoren-9-ylmethoxycarbonyl and R 4 is pentadecyl; or

R 2 is allyl, R 3 is 9H-fluoren-9-ylmethoxycarbonyl and R 4 is pentadecyl.

10. The compound of claim 1 , wherein R 2 is hydrogen, R 3 is 9H-fluoren-9-ylmethoxycarbonyl and R 4 is C 15 -alkyl.

11. The compound of claim 1 , wherein R 2 is allyl, R 3 is 9H-fluoren-9-ylmethoxycarbonyl and R 4 is C 15 -alkyl.

12. The compound of claim 1 , wherein R 2 is hydrogen, R 3 is 9H-fluoren-9-ylmethoxycarbonyl and R 4 is pentadecyl.

13. The compound of claim 1 , wherein R 2 is allyl, R 3 is 9H-fluoren-9-ylmethoxycarbonyl and R 4 is pentadecyl.

14. A compound of the formula

wherein,

R 1 is t-butyl,

R 2 is hydrogen or an ester protecting group,

R 3 is hydrogen or an amino protecting group, and

R 4 is C 12-20 -alkyl,

and salts thereof.

15. The compound of claim 14 , wherein,

R 2 is hydrogen, R 3 is 9H-fluoren-9-ylmethoxycarbonyl and R 4 is C 15 -alkyl; or

R 2 is allyl, R 3 is 9H-fluoren-9-ylmethoxycarbonyl and R 4 is C 15 -alkyl.

16. The compound of claim 14 , wherein,

R 2 is hydrogen, R 3 is 9H-fluoren-9-ylmethoxycarbonyl and R 4 is pentadecyl; or

R 2 is allyl, R 3 is 9H-fluoren-9-ylmethoxycarbonyl and R 4 is pentadecyl.

17. The compound of claim 1 , wherein R 2 is allyl.

18. The compound of claim 7 , wherein R 2 is hydrogen or allyl.

19. The compound of claim 7 , wherein R 3 is 9H-fluoren-9-ylmethoxycarbonyl.

20. The compound of claim 7 , wherein R 4 is C 14-16 -alkyl.

21. The compound of claim 7 wherein R 2 is allyl.

22. The compound of claim 14 , wherein R 2 is hydrogen or allyl.

23. The compound of claim 14 , wherein R 3 is 9H-fluoren-9-ylmethoxycarbonyl.

24. The compound of claim 14 , wherein R 4 is C 14-16 -alkyl.

25. The compound of claim 14 , wherein R 2 is allyl.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2016
From: PUENTENER, KURT
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 038439/0222 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2016
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 038439/0277 →
Priority Claims (1)
EP 12168119 · May 15, 2012 · regional
Continuity (2)
Continuation PCTEP2013059759 · May 13, 2013
Related Publication 20150073173A1 · Mar 12, 2015